Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-07 08:01 am Purchase | 2023-12-31 | 13G | Savara Inc. SVRA | ADAGE CAPITAL PARTNERS GP L.L.C. | 7,637,930 5.640% | 773,379 (+11.27%) | Filing History |
| 2024-02-01 3:50 pm Purchase | 2023-12-31 | 13G | Savara Inc. SVRA | Farallon Capital Partners L.P. | 14,326,911 9.990% | 14,326,911 (New Position) | Filing History |
| 2024-01-31 2:08 pm Purchase | 2023-12-31 | 13G | Savara Inc. SVRA | BlackRock Inc. BLK | 7,261,530 5.400% | 4,132,550 (+132.07%) | Filing History |
| 2023-07-26 4:57 pm Purchase | 2023-07-17 | 13D | Savara Inc. SVRA | Growth Equity Opportunities 17 LLC | 24,471,264 18.100% | 333,333 (+1.38%) | Filing History |
| 2023-07-25 4:17 pm Purchase | 2023-07-17 | 13G | Savara Inc. SVRA | TCG Crossover GP I, LLC | 10,000,000 7.400% | 10,000,000 (New Position) | Filing History |
| 2023-07-19 4:30 pm Purchase | 2023-07-17 | 13D | Savara Inc. SVRA | Bain Capital Life Sciences Fund II L.P. | 14,232,751 13.000% | 2,610,153 (+22.46%) | Filing History |
| 2023-02-14 4:06 pm Purchase | 2022-12-31 | 13G | Savara Inc. SVRA | Venrock Healthcare Capital Partners II L.P. | 6,351,531 5.600% | 6,351,531 (New Position) | Filing History |
| 2022-02-14 3:52 pm Unchanged | 2021-12-31 | 13G | Savara Inc. SVRA | CAXTON CORP | 6,896,551 6.100% | 0 (Unchanged) | Filing History |
| 2022-02-14 2:15 pm Unchanged | 2020-12-31 | 13G | Savara Inc. SVRA | EcoR1 Capital LLC | 3,040,540 5.300% | 0 (Unchanged) | Filing History |
| 2022-02-10 11:02 am Sale | 2021-12-31 | 13G | Savara Inc. SVRA | ADAGE CAPITAL PARTNERS GP L.L.C. | 6,864,551 6.030% | -432,000 (-5.92%) | Filing History |
| 2021-04-09 6:02 pm Purchase | 2021-03-31 | 13G | Savara Inc. SVRA | BlackRock Inc. BLK | 3,128,980 2.800% | 118,950 (+3.95%) | Filing History |
| 2021-03-25 5:10 pm Purchase | 2021-03-15 | 13D | Savara Inc. SVRA | Growth Equity Opportunities 17 LLC | 24,137,931 24.200% | 24,137,931 (New Position) | Filing History |
| 2021-03-25 4:05 pm Purchase | 2021-03-15 | 13G | Savara Inc. SVRA | ADAGE CAPITAL PARTNERS GP L.L.C. | 7,296,551 6.530% | 7,296,551 (New Position) | Filing History |
| 2021-03-19 4:53 pm Purchase | 2021-03-11 | 13G | Savara Inc. SVRA | CAXTON CORP | 6,896,551 6.200% | 6,896,551 (New Position) | Filing History |
| 2021-03-17 4:15 pm Purchase | 2021-03-15 | 13D | Savara Inc. SVRA | Bain Capital Life Sciences Fund II L.P. | 11,622,598 13.000% | 6,494,005 (+126.62%) | Filing History |
| 2021-02-16 09:49 am Unchanged | 2020-12-31 | 13G | Savara Inc. SVRA | EcoR1 Capital LLC | 3,040,540 5.300% | 0 (Unchanged) | Filing History |
| 2021-02-12 5:48 pm Sale | 2020-12-31 | 13G | Savara Inc. SVRA | EcoR1 Capital LLC | 3,040,540 5.300% | -1,432,664 (-32.03%) | Filing History |
| 2021-02-02 3:13 pm Purchase | 2020-12-31 | 13G | Savara Inc. SVRA | BlackRock Inc. BLK | 3,010,030 5.600% | 710,907 (+30.92%) | Filing History |